Tuberculosis and Respiratory Diseases

  • 제87권3호
  • /
  • Pages.349-356
  • /
  • 2024
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Clinical Characteristics, Risk Factors, and Outcomes of Acute Pulmonary Embolism in Thailand: 6-Year Retrospective Study

  • Pattarin Pirompanich (Division of Pulmonology and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Thammasat University) ;
  • Ornnicha Sathitakorn (Division of Hematology, Department of Medicine, Faculty of Medicine, Thammasat University) ;
  • Teeraphan Suppakomonnun (Department of Medicine, Faculty of Medicine, Thammasat University) ;
  • Tunlanut Sapankaew (Department of Medicine, Faculty of Medicine, Thammasat University)
  • 투고 : 2023.08.02
  • 심사 : 2024.02.27
  • 발행 : 2024.07.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Acute pulmonary embolism (APE) is a fatal disease with varying clinical characteristics and imaging. The aim of this study was to define the clinical characteristics, risk factors, and outcomes in patients with APE at a university hospital in Thailand. Methods: Patients diagnosed with APE and admitted to our institute between January 1, 2017 and December 31, 2022 were retrospectively enrolled. The clinical characteristics, investigations, and outcomes were recorded. Results: Over the 6-year study period, 369 patients were diagnosed with APE. The mean age was 65 years; 64.2% were female. The most common risk factor for APE was malignancy (46.1%). In-hospital mortality rate was 23.6%. The computed tomography pulmonary artery revealed the most proximal clots largely in segmental pulmonary artery (39.0%), followed by main pulmonary artery (36.3%). This distribution was consistent between survivors and non-survivors. Multivariate logistic regression analysis revealed that APE mortality was associated with active malignancy, higher serum creatinine, lower body mass index (BMI), and tachycardia with adjusted odds ratio (95% confidence interval [CI]) of 3.70 (1.59 to 8.58), 3.54 (1.35 to 9.25), 2.91 (1.26 to 6.75), and 2.54 (1.14 to 5.64), respectively. The prediction model was constructed with area under the curve of 0.77 (95% CI, 0.70 to 0.84). Conclusion: The overall mortality rate among APE patients was 23.6%, with APE-related death accounting for 5.1%. APE mortality was associated with active malignancy, higher serum creatinine, lower BMI, and tachycardia.

키워드

과제정보

The authors would like to express our gratitude to Thammasat University Hospital for providing the patient data and to Sam Ormond for reviewing the English language use in our manuscript.

참고문헌

  1. Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016;388:3060-73. 
  2. Keller K, Hobohm L, Ebner M, Kresoja KP, Munzel T, Konstantinides SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 2020;41:522-9. 
  3. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016;118:1340-7. 
  4. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019;54:1901647. 
  5. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64. 
  6. Bumroongkit C, Deesomchok A, Liwsrisakun C, Pothirat C, Theerakittikul T, Limsukon A, et al. Clinical characteristics, risk factors, and outcomes of acute pulmonary embolism in Asian population. J Clin Med 2022;11:6954. 
  7. Kahn SR, de Wit K. Pulmonary embolism. N Engl J Med 2022;387:45-57. 
  8. Laporte S, Mismetti P, Decousus H, Uresandi F, Otero R, Lobo JL, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008;117:1711-6. 
  9. Makarawate P, Chaosuwannakit N, Thongkrau T, Keeratikasikorn C, Sawanyawisuth K. Clinical factors associated with death from acute pulmonary embolism in Thailand. Asian Biomed 2016;10:129-32. 
  10. Yu S, Zhou H, Li Y, Song J, Shao J, Wang X, et al. PERFORM: pulmonary embolism risk score for mortality in computed tomographic pulmonary angiography-confirmed patients. EClinicalMedicine 2021;36:100897. 
  11. Collins GS, Reitsma JB, Altman DG, Moons KG; TRIPOD Group. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group. Circulation 2015;131:211-9. 
  12. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-6. 
  13. Luijten D, Talerico R, Barco S, Cannegieter SC, Delcroix M, Ende-Verhaar YM, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis. Eur Respir J 2023;62:2300449. 
  14. Puengpapat S, Pirompanich P. Incidence of chronic thromboembolic pulmonary hypertension in Thammasat University Hospital. Lung India 2018;35:373-8. 
  15. Chiansirikraivuti N, Sapankaew T, Pirompanich P. Clinical characteristics of pulmonary hypertension patients who underwent right heart catheterization in Thailand: 5-year retrospective single-centre study. Lung India 2023;40:42-7.